Press release
August 13, 2026
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Instil Bio, Inc. (TIL)
DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its second quarter 2026 financial results and provided a corporate update.